HD-OPM Archive
Topics › Statins

Atorvastatin protected arteries from anthracycline chemotherapy damage in an RCT

Louis Nervegna · Jan 26, 2026 · ♥ 17 reactions · 0 comments · original Facebook post
StatinsBlood vessels, circulation & endothelium
AI summary & key facts

Louis highlights a JAMA Cardiology trial in which atorvastatin before and during anthracycline chemotherapy led to fewer cases of elevated pulse wave velocity and less aortic distensibility loss than placebo, illustrating statin effects beyond LDL.

This is an amazing study.

Atorvastatin seems to protect arteries against cytotoxic chemotherapy used in cancer treatment.

This has very little to do with LDL.

It is an example of the beneficial pleiotropic effects that statins have on the cardiovascular system.

Quoted:

“The pleiotropic cardiovascular protective effects of statins extend beyond lipid-lowering and include anti-inflammatory, antioxidant, and antifibrotic properties [19-22]. In the Statins to Prevent the Cardiotoxicity From Anthracyclines (STOP-CA) randomized clinical trial (RCT), pretreatment with atorvastatin was associated with lower odds of a significant decline in left ventricular ejection fraction (LVEF) among patients with lymphoma undergoing anthracycline-based chemotherapy [23]. The primary imaging modality of the STOP-CA trial was cardiac magnetic resonance imaging (MRI), which is a robust, established noninvasive modality to accurately measure aortic function [24]. This created a unique opportunity to evaluate the association of statin therapy with aortic function. Therefore, in this subanalysis of the STOP-CA trial, we tested whether atorvastatin is associated with protection against anthracycline-associated aortic dysfunction (vascular aging), assessed by cardiac MRI-derived aortic arch pulse wave velocity and aortic distensibility.”

“In this secondary analysis of 300 participants with lymphoma enrolled in the STOP-CA (Statins to Prevent the Cardiotoxicity From Anthracyclines) randomized clinical trial, atorvastatin was associated with significantly lower odds of an increase (≥0.8 m per second) in magnetic resonance imaging–derived aortic arch pulse wave velocity, compared with placebo. The proportion of participants meeting this primary exploratory end point was significantly lower with atorvastatin (5%), compared with placebo (50%).”

“These findings suggest that pretreatment with atorvastatin is associated with preserved vascular function in patients undergoing anthracycline treatment.”

#statinsHD #atorvastatinHD #statinspleiotropyHD

Research cited

Statin therapy before and during anthracycline-based chemotherapy resulted in fewer cases of elevated pulse wave velocity and reduced aortic distensibility compared with placebo. The results suggest a potential protective effect of atorvastatin against vascular dysfunction in cancer survivors. Atorvastatin and Aortic Stiffness During Anthracycline-Based Chemotherapy (JAMA Cardiol, 2026)

No photo description available.
← newer: Two days of oatmeal lowered LDL about 10% for up to 6 weeks older: HD-OPM Food Pyramid: Mediterranean-inspired alternative to t →